79 Article(s)
Pub. Date
#Total Relationship(s)
1 1315917 D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons. Brain Res Mol Brain Res 1992 Mar 3
2 2208388 Synthesis and in vitro affinity for dopamine D-2 receptor of N-fluorine-substituted analogs of eticlopride. Chem Pharm Bull (Tokyo) 1990 Jun 1
3 7535410 GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment. Neurosci Lett 1994 Oct 24 2
4 7595569 Differential effects of D1 and D2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced up-regulation of zif/268 mRNA expression in rat forebrain. J Neurochem 1995 Dec 4
5 7830888 Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist. Neuroscience 1994 Sep 2
6 7855736 Amphetamine- and cocaine-induced fos in the rat striatum depends on D2 dopamine receptor activation. Synapse 1994 Nov 3
7 7908600 Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres. Brain Res 1993 Dec 31 1
8 7916439 The selective D2 dopamine receptor antagonist eticlopride counteracts the ejaculatio praecox induced by the selective D2 dopamine agonist SND 919 in the rat. Life Sci 1994 1
9 7965077 Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J Neurosci 1994 Nov 1
10 8029261 The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats. Pharmacol Biochem Behav 1994 Apr 1
11 8171043 Comparison of the forms of the dopamine D2 receptor expressed in GH4C1 cells. Proc Soc Exp Biol Med 1994 Mar 1
12 8624698 Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors. Brain Res 1995 Nov 27 1
13 8836570 Development of striatal dopaminergic function. II: Dopaminergic regulation of transcription of the immediate early gene zif268 and of D1 (D1a) and D2 (D2a) receptors during pre- and postnatal development. Brain Res Dev Brain Res 1996 Jul 20 2
14 9027868 Reduced eticlopride-induced Fos expression in caudate-putamen and globus pallidus after unilateral frontal cortex injury: relation to neglect. Neuroscience 1997 Feb 5
15 9111066 Bromocriptine transcriptionally activates the multidrug resistance gene (pgp2/mdr1b) by a novel pathway. J Biol Chem 1997 Apr 25 3
16 9262200 Treadmill running induces striatal Fos expression via NMDA glutamate and dopamine receptors. Exp Brain Res 1997 Jul 1
17 9300403 Differing influences of dopamine agonists and antagonists on Fos expression in identified populations of globus pallidus neurons. Neuroscience 1997 Nov 3
18 9614253 Substance P modulates NMDA responses and causes long-term protein synthesis-dependent modulation of the lamprey locomotor network. J Neurosci 1998 Jun 15 2
19 10027854 Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems. J Pharmacol Exp Ther 1999 Mar 1
20 10077330 Local infusion of the (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione does not block D1 dopamine receptor-mediated increases in immediate early gene expression in the dopamine-depleted striatum. Neuroscience 1999 Mar 2
21 10363818 Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons. Neuroscience 1999 2
22 10381545 Locomotor-activity-induced changes in striatal levels of preprotachykinin and preproenkephalin mRNA. Regulation by the dopaminergic and glutamatergic systems. Brain Res Mol Brain Res 1999 Jun 18 1
23 10500224 D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc Natl Acad Sci U S A 1999 Sep 28 1
24 10506202 Decreased c-fos responses to dopamine D(1) receptor agonist stimulation in mice deficient for D(3) receptors. J Biol Chem 1999 Oct 8 2
25 10594669 Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat. Eur J Neurosci 1999 Dec 1
26 10677546 Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A 2000 Feb 15 2
27 11082443 Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. J Pharmacol Exp Ther 2000 Dec 1
28 11102574 Degree of immediate early gene induction in striatum by eticlopride determines sensitivity to N-methyl-D-aspartate receptor blockade. Brain Res 2000 Dec 8 1
29 11224389 The effects of dopamine agonists on rotational behavior in non-tolerant and caffeine-tolerant rats. Behav Pharmacol 1995 Dec 1
30 11279288 Examination of the involvement of protein kinase A in D2 dopamine receptor antagonist-induced immediate early gene expression. J Neurochem 2001 Apr 2
31 11408534 Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat. J Pharmacol Exp Ther 2001 Jul 2
32 11906713 Phencyclidine increases vesicular dopamine uptake. Eur J Pharmacol 2002 Mar 1 1
33 11923462 Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. J Neurosci 2002 Apr 1 1
34 11955716 Further characterization of preproenkephalin mRNA-containing cells in the rodent globus pallidus. Neuroscience 2002 2
35 12351745 Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. J Neurosci 2002 Oct 1 1
36 12490616 Molecular and behavioral interactions between central melanocortins and cocaine. J Pharmacol Exp Ther 2003 Jan 1
37 12808005 Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. J Pharmacol Exp Ther 2003 Sep 1
38 12871586 Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. J Neurochem 2003 Jul 2
39 12885788 Blunted fenfluramine-evoked prolactin secretion in hypertensive rats. Hypertension 2003 Oct 1
40 12921866 Pramipexole increases vesicular dopamine uptake: implications for treatment of Parkinson's neurodegeneration. Eur J Pharmacol 2003 Aug 8 3
41 15305880 Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol. Eur J Neurosci 2004 Aug 2
42 15343065 Blockade of D2 dopamine receptors in the VTA induces a long-lasting enhancement of the locomotor activating effects of amphetamine. Behav Pharmacol 2004 Sep 1
43 15634779 Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons. J Neurosci 2005 Jan 5 1
44 15713275 Dopamine manipulation alters immediate-early gene response of striatal parvalbumin interneurons to cortical stimulation. Brain Res 2005 Feb 21 1
45 16336634 Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors. J Neurochem 2006 Jan 1
46 16539683 Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors. J Neurochem 2006 Mar 1
47 17706924 Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 Co-immunoprecipitation and fluorescence resonance energy transfer analysis. Cell Signal 2007 Nov 1
48 19048234 The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists. Psychopharmacology (Berl) 2009 Apr 3
49 19141713 Mechanisms underlying methamphetamine-induced dopamine transporter complex formation. J Pharmacol Exp Ther 2009 Apr 3
50 19562697 Regulation of dynamin 2 and G protein-coupled receptor kinase 2 in rat nucleus accumbens during acute and repeated cocaine administration. Synapse 2009 Oct 2